This trial is completed!
Search for a recruiting clinical trial for your condition
Your journey
1What's a trial
4Get in touch
More info
You can access this
clinical trial
if you have
Lipid Metabolism Disorders or Peroxidase; Defect
and you are
over 18
years old
This is an advanced phase trial assessing
the effectiveness of the new treatment before being released on the market.
Show me locations

The purpose

The objective of this study is to evaluate the effect of omega 3 fatty acid on neurological recovery, lipid profile and Antioxidant system in patients with spinal cord injury. One hundred spinal cord injured patients who come to clinic of spinal injury repair research center selected. Then the patients will receive two supplements capsules of omega 3 (600 mg) in the intervention group and placebo in the control group. Primary outcome measures are professionals evaluation of neurological function by using : - ASIA scale for sensory and motor function - FIM scale for Functional potential - FAM - SF_36 for quality of life Lipid profile and Antioxidant profile evaluation by using: - FBS - 2hpp - Insulin - LDL - Total cHOL - TG - HDL - Leptin Adiponectin -Calcium- - 25OHD - PTH,LH, FSH, Prolactin,Testosterone in males Bone markers by serum levels of :Osteocalcin-Osteoprotegrin_Bone Specified ALP- CTX - RANKL - BMD

Provided treatments

  • : w3 supplement in SCI
  • Other: placebo

Locations near you

Unfortunately, there are no recruiting locations near you. Please check the list with all locations below.
Tris trial is registered with FDA with number: NCT01311375. The sponsor of the trial is Tehran University of Medical Sciences and it is looking for 100 volunteers for the current phase.
Official trial title:
Evaluation of Omega 3 Supplementation on Neurological Recovery , Lipid Profile and Antioxidant Enzymes and Hormones After Chronic Spinal Cord Injury.